High serum levels of galectin-1 observed in obesity, is a risk factor for developing T2D over time and is associated with poor outcome in several malignant cancers including prostate cancer and ovarian cancer [7, 9, 27–29]. This evidence concerns the gene LGALS1 and prostate cancer.